Diagnostic imaging of malignant melanoma with radiolabeled antitumor antibodies

S. M. Larson, J. A. Carrasquillo, K. A. Krohn, R. W. McGuffin, D. L. Williams, I. Hellström, D. Lyster

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

Tumor-specific monoclonal antibodies offer the potential for improved diagnosis of and therapy for malignant neoplasms. We have used iodine 131- and iodine 123-radiolabeled murine monoclonal immunoglobulin and Fab fragments against p97, a 97,000 molecular weight, melanoma-associated antigen on the cell surface, to image metastatic tumor deposits in patients with malignant melanoma.

Original languageEnglish (US)
Pages (from-to)811-812
Number of pages2
JournalJournal of the American Medical Association
Volume249
Issue number6
DOIs
StatePublished - Sep 1 1983

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Diagnostic imaging of malignant melanoma with radiolabeled antitumor antibodies'. Together they form a unique fingerprint.

  • Cite this

    Larson, S. M., Carrasquillo, J. A., Krohn, K. A., McGuffin, R. W., Williams, D. L., Hellström, I., & Lyster, D. (1983). Diagnostic imaging of malignant melanoma with radiolabeled antitumor antibodies. Journal of the American Medical Association, 249(6), 811-812. https://doi.org/10.1001/jama.249.6.811